Canada markets closed

Tarsus Pharmaceuticals, Inc. (TARS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
32.04-0.17 (-0.53%)
At close: 04:00PM EDT
32.04 0.00 (0.00%)
After hours: 05:32PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.20B
Enterprise Value 1.00B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)53.96
Price/Book (mrq)6.10
Enterprise Value/Revenue 57.56
Enterprise Value/EBITDA -7.62

Trading Information

Stock Price History

Beta (5Y Monthly) 1.05
52-Week Change 3110.51%
S&P500 52-Week Change 322.36%
52 Week High 340.40
52 Week Low 312.57
50-Day Moving Average 333.92
200-Day Moving Average 322.65

Share Statistics

Avg Vol (3 month) 3723.87k
Avg Vol (10 day) 3364.24k
Shares Outstanding 537.5M
Implied Shares Outstanding 637.5M
Float 824.39M
% Held by Insiders 14.26%
% Held by Institutions 188.02%
Shares Short (Apr 15, 2024) 47.9M
Short Ratio (Apr 15, 2024) 413.48
Short % of Float (Apr 15, 2024) 422.07%
Short % of Shares Outstanding (Apr 15, 2024) 421.07%
Shares Short (prior month Mar 15, 2024) 47.2M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-339.94%

Management Effectiveness

Return on Assets (ttm)-36.27%
Return on Equity (ttm)-69.71%

Income Statement

Revenue (ttm)17.45M
Revenue Per Share (ttm)0.59
Quarterly Revenue Growth (yoy)30.80%
Gross Profit (ttm)N/A
EBITDA -142.28M
Net Income Avi to Common (ttm)-135.89M
Diluted EPS (ttm)-4.62
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)227.44M
Total Cash Per Share (mrq)6.65
Total Debt (mrq)31.73M
Total Debt/Equity (mrq)16.11%
Current Ratio (mrq)6.93
Book Value Per Share (mrq)5.76

Cash Flow Statement

Operating Cash Flow (ttm)-117.49M
Levered Free Cash Flow (ttm)-74.48M